Comparison of Semantic and Episodic Memory BOLD fMRI Activation in Predicting Cognitive Decline in Older Adults by Hantke, Nathan et al.
Marquette University
e-Publications@Marquette
Psychology Faculty Research and Publications Psychology, Department of
1-1-2013
Comparison of Semantic and Episodic Memory
BOLD f MRI Activation in Predicting Cognitive







Leslie M. Guidotti Breting
Rosalind Franklin University of Medicine and Science
Alissa Butts
Marquette University, alissa.butts@marquette.edu
See next page for additional authors
Published version. Journal of the International Neuropsychological Society, Vol. 19, No. 1 ( January
2013): 11-21. DOI. Material on these pages is copyright Cambridge University Press or reproduced
with permission from other copyright owners. It may be downloaded and printed for personal
reference, but not otherwise copied, altered in any way or transmitted to others (unless explicitly
stated otherwise) without the written permission of Cambridge University Press. Hypertext links to
other Web locations are for the convenience of users and do not constitute any endorsement or
authorisation by Cambridge University Press.
Authors
Nathan Hantke, Kristy A. Nielson, John L. Woodard, Leslie M. Guidotti Breting, Alissa Butts, Michael
Seidenberg, J. Carson Smith, Sally Durgerian, Melissa A. Lancaster, Monica Matthews, Michael Sugarman,
and Stephen M. Rao
This article is available at e-Publications@Marquette: https://epublications.marquette.edu/psych_fac/81
Journal of the International Neuropsychological Society (2013), 19, 11–21.
Copyright E INS. Published by Cambridge University Press, 2012.
doi:10.1017/S1355617712000951
Comparison of Semantic and Episodic Memory BOLD
fMRI Activation in Predicting Cognitive Decline in
Older Adults
Nathan Hantke,1 Kristy A. Nielson,1,2 John L. Woodard,3 Leslie M. Guidotti Breting,4 Alissa Butts,1
Michael Seidenberg,4 J. Carson Smith,5 Sally Durgerian,2 Melissa Lancaster,4 Monica Matthews,4
Michael A. Sugarman,3 AND Stephen M. Rao6
1Department of Psychology, Marquette University, Milwaukee, Wisconsin
2Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin
3Department of Psychology, Wayne State University, Detroit, Michigan
4Department of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois
5Department of Kinesiology, University of Maryland, College Park, Maryland
6Neurological Institute, Cleveland Clinic, Cleveland, Ohio
(RECEIVED December 21, 2011; FINAL REVISION July 5, 2012; ACCEPTED July 6, 2012)
Abstract
Previous studies suggest that task-activated functional magnetic resonance imaging (fMRI) can predict future cognitive
decline among healthy older adults. The present fMRI study examined the relative sensitivity of semantic memory (SM)
versus episodic memory (EM) activation tasks for predicting cognitive decline. Seventy-eight cognitively intact elders
underwent neuropsychological testing at entry and after an 18-month interval, with participants classified as cognitively
‘‘Stable’’ or ‘‘Declining’’ based onZ1.0 SD decline in performance. Baseline fMRI scanning involved SM (famous name
discrimination) and EM (name recognition) tasks. SM and EM fMRI activation, along with Apolipoprotein E (APOE)
e4 status, served as predictors of cognitive outcome using a logistic regression analysis. Twenty-seven (34.6%)
participants were classified as Declining and 51 (65.4%) as Stable. APOE e4 status alone significantly predicted
cognitive decline (R25 .106; C index5 .642). Addition of SM activation significantly improved prediction accuracy
(R25 .285; C index5 .787), whereas the addition of EM did not (R25 .212; C index5 .711). In combination with
APOE status, SM task activation predicts future cognitive decline better than EM activation. These results have
implications for use of fMRI in prevention clinical trials involving the identification of persons at-risk for age-associated
memory loss and Alzheimer’s disease. (JINS, 2013, 19, 11–21)
Keywords: Magnetic resonance imaging, Aging, Apolipoprotein-E, Memory loss, Mild cognitive impairment,
Longitudinal study
INTRODUCTION
Genetic risk factors, such as the presence of one or both
Apolipoprotein-E (APOE) e4 alleles, have been associated
with increased risk for Alzheimer’s disease (AD) and late-life
cognitive decline (Caselli et al., 1999; Farrer et al., 1997;
Saunders et al., 1996; Swan, Lessov-Schlaggar, Carmelli,
Schellenberg, & La Rue, 2005). Cross-sectional studies sug-
gest that asymptomatic elders with risk factors for AD (i.e.,
APOE e4 carriers and persons with a family history of AD)
demonstrate different patterns of brain activation on
functional magnetic resonance imaging (fMRI) than elders
without risk factors (for a review, see Wierenga & Bondi,
2007). Often, these activation changes occur in brain regions
critical for memory processes, such as the hippocampus,
posterior cingulate, and lateral posterior temporoparietal
regions. Such regions are also the earliest to be affected by AD
neuropathology (Bassett et al., 2006; Bondi, Houston, Eyler,
& Brown, 2005; Johnson et al., 2006; Seidenberg et al., 2009;
Sperling et al., 2010).
Aberrant patterns of task-activated fMRI may precede the
onset of cognitive symptoms and atrophy on structural MRI
in elders at-risk for AD (Seidenberg et al., 2009). Several
longitudinal studies suggest that task-activated fMRI may be
Correspondence and reprint requests to: Stephen M. Rao, Schey Center
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useful for predicting future cognitive decline in intact elders
(Bookheimer et al., 2000; Lind et al., 2006; O’Brien et al.,
2010; Persson et al., 2006; Smith et al., 2005; Woodard et al.,
2010) and in patients with mild cognitive impairment (MCI),
the prodromal condition typically preceding the diagnosis of
AD (Miller et al., 2008). The majority of these fMRI
prediction studies have used episodic memory (EM) tasks
(Bookheimer et al., 2000; Miller et al., 2008; O’Brien et al.,
2010; Persson et al., 2006), which is not surprising because
EM dysfunction is among the most prominent of cognitive
changes in the 3-year period preceding a diagnosis of AD
(Mickes et al., 2007). EM tasks have been used widely in
cross-sectional fMRI studies to contrast cognitively intact
individuals at varying risk for developing AD (Trivedi et al.,
2008; Wierenga & Bondi, 2007). However, there exist
potential methodological problems in using EM tasks during
fMRI. EM performance declines with healthy aging and is
accelerated in MCI and AD (Bondi & Kaszniak, 1991).
The interpretation of fMRI activation maps is complicated
when performance varies across participants. This issue is
particularly problematic for blocked trial designs, where the
calculated fMRI response is based on the average of both
correct and incorrect trials within a block, as the incorpora-
tion of incorrect trials may result in activation of unintended,
non–memory-related processes. In an event-related fMRI
design, it is possible to eliminate error trials from the brain
maps, but even this procedure may be invalid if performance
is close to chance. In addition, EM tasks are inherently
difficult for older adults, resulting in potential activation of
brain regions associated with increased effort rather than the
memory circuits of interest.
Alternatively, semantic memory (SM) fMRI tasks have
also successfully predicted future cognitive decline (Lind
et al., 2006; Smith et al., 2005; Woodard et al., 2010) and
may have some advantages over EM tasks. Performance
declines on SM tasks are less severe than EM declines in
normal aging and MCI (Hodges & Patterson, 1995). In
addition, SM tasks are typically less effortful for older adults
than EM tasks. Finally, brain regions recruited in response
to SM tasks overlap with the so-called ‘‘default mode
network’’ (DMN), a circuit activated during rest and during
semantic processing (Binder, Desai, Graves, & Conant,
2009). Regions in this network are susceptible to early AD
pathology, including amyloid-beta deposition (Buckner
et al., 2005; Pihlajamaki & Sperling, 2009; Raichle et al.,
2001; Rombouts & Scheltens, 2005). Thus, SM fMRI tasks
may be sensitive to the detection of risk for future cognitive
decline and AD.
We published a series of fMRI studies using a famous
name discrimination task (FNDT) to probe SM networks in
at-risk aging and in MCI (Sugarman et al., 2012). Seidenberg
et al. (2009) found greater SM activation in individuals
at-risk for AD, especially in the posterior cingulate and lateral
posterior temporoparietal regions. Increased SM activation in
the same regions was also found in MCI patients as compared
to healthy older adults, despite equivalent task performance
(Woodard et al., 2009). Recently, Woodard et al. (2010)
demonstrated that SM task activation was more effective
in predicting future cognitive decline than hippocampal
volumes in elders who were cognitively intact at study entry.
In the current study of cognitively intact healthy elders, we
compared the accuracy of EM and SM fMRI brain activation
patterns in predicting future cognitive decline after an
18-month retest interval. The FNDT served as the SM task;
the EM task involved an old-new recognition task involving
famous and unfamiliar names. To equate the brain maps
derived from the two tasks, we used an event-related design
to eliminate error trials from the image analyses. In addition,
a principal components analysis was used to reduce the
number of predictors derived from the SM and EM fMRI
activation data. We predicted that task performance would
be poorer on the EM task relative to the SM task, and that
activation during the SM task would be the superior predictor
of future cognitive decline.
METHOD
Participants
Participants were 78 healthy older adults (73% female; mean
age5 73 years; SD5 4.9 years; mean education5 14.9 years;
SD5 2.7 years). They were drawn from a larger sample of 459
community-dwelling adults who were recruited via newspaper
advertisements. Following telephone screening, 92 participants
met study inclusion and exclusion criteria. Participants were
excluded from the study if they had a history or evidence of:
(1) neurological illnesses or conditions including dementia
and head trauma with a loss of consciousness greater than
30 min; (2) medical illnesses or conditions that may affect brain
function (such as untreated hypertension or insulin-dependent
diabetes mellitus); (3) major psychiatric disturbance meeting
DSM-IV Axis I criteria; (4) a Mini-Mental State Exam
(MMSE) (Folstein, Folstein, & McHugh, 1975) score less than
28; (5) a Geriatric Depression Scale (Yesavage et al., 1982)
score greater than 10; (6) substance abuse meeting DSM-IV
Axis I criteria; (7) impairments in activities of daily living as
determined by the Lawton Instrumental Activities of Daily
Living Scale (ADL) (Lawton & Brody, 1969); (8) taking
prescribed psychoactive medications, (9) a Hachinski ischemia
score above 4; or (10) left-handedness, as determined by the
Edinburgh Handedness Inventory (Oldfield, 1971). Of the
92 participants who met study criteria, 81 persons agreed
to undergo APOE genotyping from blood samples, a neuro-
psychological evaluation, and an fMRI scanning session. MRI
data were not successfully obtained from 3 participants, leaving
78 participants for inclusion.
Family history was defined as a report of a clear clinical
diagnosis of AD or a reported history of gradual decline in
memory and other cognitive functions, confusion, or judg-
ment problems without a formal diagnosis of AD before
death in a first-degree relative. One participant reported a
diagnosis of AD in a second-degree relative, with some mild
cognitive changes noted in a parent before the parent’s death.
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Because our study examined the influence of AD risk factors
on prediction of cognitive decline, approximately half
(51.3%) of the participants were purposely selected because
they had a positive family history of AD. In addition, 33.3%
of the sample carried at least one APOE e4 allele. All
participants underwent neuropsychological evaluation (see
below) and were determined to be cognitively intact at
baseline. Informed consent was obtained consistent with
the Declaration of Helsinki and institutional guidelines
established by the Medical College of Wisconsin Human
Subjects Review Committee. All participants received
financial compensation for their participation.
Neuropsychological Assessment and APOE
Genotyping
All participants underwent a baseline and 18-month follow-
up neuropsychological battery consisting of the following:
MMSE (Folstein et al., 1975), Mattis Dementia Rating
Scale-2 (Jurica, Leitten, & Mattis, 2001; Mattis, 1988), Rey
Auditory Verbal Learning Test (RAVLT) (Rey, 1958),
Geriatric Depression Scale (Yesavage et al., 1982), and ADL
(Lawton & Brody, 1969). Alternate forms of the DRS-2
(Schmidt, 2004; Schmidt, Mattis, Adams, & Nestor, 2005)
and RAVLT (Schmidt, 1996) were administered during
the follow-up examination. Participant APOE genotype was
determined using a polymerase chain reaction method
described by Saunders et al. (1996). DNA was isolated with
the Gentra Systems Autopure LS for Large Sample Nucleic
Acid Purification.
Definition of Cognitive Decline
Membership into the Declining group (n5 27) was defined as a
reduction of at least one standard deviation between baseline
and follow-up testing on one or more of the following neuro-
psychological measures: DRS-2 Total Score (DRS-2 Tot),
RAVLT Sum of Trials 1-5 (RAVLT-Tot), or RAVLT Delayed
Recall (RAVLT-DR). Residualized change scores were
computed for each cognitive measure by predicting retest
scores using baseline scores. This procedure adjusts for base-
line performance, practice effects, and regression to the mean.
Participants with standardized residuals of 21.0 or lower
on one or more of the three measures were assigned to the
cognitively declining group; the remaining participants were
classified as cognitively stable.
fMRI Task
All participants were administered SM and EM tasks
while undergoing fMRI in the same scanning session.
Corrective lenses were provided to participants as needed.
The SM task consisted of the presentation of 30 highly
recognizable famous names and 30 unfamiliar names.
Stimuli were selected from an original pool of 784 names
based on the ability of healthy older adults to correctly
classify each name as famous or unfamiliar (see Douville
et al., 2005, for details). The 60 names were randomly
interspersed with 20 presentations of a centrally placed
fixation crosshair to introduce ‘‘jitter’’ into the fMRI time
series (inter-stimulus interval5 4 s). Participants made a
right index or right middle finger key press for famous
or unfamiliar names, respectively. Accuracy and reaction
time were recorded. The imaging run began and ended with
12 s of fixation and was 5 min and 44 s in duration.
Following a 20-min delay, participants were administered
an EM recognition task. The stimuli consisted of 60 ‘‘old’’
items (the 30 famous and 30 unfamiliar names from the SM
task) randomly intermixed with 60 ‘‘new’’ items (30 famous
and 30 unfamiliar names). Participants were asked to indicate
by button press if the name was old (right index finger) or
new (right middle finger). As in the SM task, name stimuli
were presented for 4 s and presented in a pseudorandom order
with 40 presentations of a centrally placed fixation crosshair
to introduce ‘‘jitter.’’ The EM task was split into two runs that
began and ended with 12 s of fixation and were each 5 min
and 44 s in duration.
Image Acquisition
Whole-brain, event-related fMRI was conducted on a
General Electric (Waukesha, WI) Signa Excite 3.0 Tesla
short bore scanner equipped with a quad split quadrature
transmit/receive head coil. Echoplanar images were collected
using an echoplanar pulse sequence (TE5 25 ms; flip
angle5 77 degrees; field of view [FOV]5 24 mm; matrix
size5 643 64). Thirty-six contiguous axial 4-mm-thick
slices were selected to provide coverage of the entire brain
(voxel size5 3.753 3.753 4 mm). The inter-scan interval
(TR) was 2 s. High-resolution, three-dimensional spoiled
gradient-recalled at steady-state (SPGR) anatomic images
were acquired (TE5 3.9 ms; TR59.5 ms; inversion recovery
[IR] preparation time5 450 ms; flip angle5 12 degrees;
number of excitations [NEX]52; slice thickness51.0 mm;
FOV5 24 cm; resolution5 2563 224). Foam padding was
used to reduce head movement within the coil.
Image Analysis
Functional images were generated with the Analysis of
Functional Neuroimages (AFNI) software package (Cox,
1996). Each image time series was shifted to the beginning of
the TR and then spatially registered to reduce the effects of
head motion using a rigid body iterative linear least squares
method. A deconvolution analysis was used to extract a
hemodynamic response function (HRF) for famous and
unfamiliar names (SM task) and for novel and previously
seen names (EM task) from the time-series. Correct and
incorrect trials were modeled separately, and only correct
trials were used in the second-level analyses. HRFs
were modeled for the 0- to 16-s period post-stimulus onset.
Motion parameters were incorporated into the model
as nuisance regressors. The HRFs were also transposed so
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that the value of the HRF at trial onset was zero. Area
under the curve (AUC) was calculated by summing the
hemodynamic responses at time points 4, 6, and 8 s
post-trial onset. Individual anatomical and functional scans
were transformed into standard stereotaxic Talairach
space (Talairach & Tournoux, 1988). To compensate for
normal variation in anatomy across participants, functional
images were blurred using a 6-mm Gaussian full-width
half-maximum filter.
Spatial Extent of Activation Analysis
A voxel-wise analysis was used to determine differences in
spatial extent of activation between the stable and declining
groups. SM task activation was defined as regions where the
AUC for famous names was significantly different from that of
unfamiliar names. EM task activation was defined as regions
where the AUC for previously shown names was significantly
greater than the AUC for novel names. For all voxel-wise
analyses, the individual voxel probability threshold was
p, .005 with a minimum cluster of 0.731 mL.The statistical
threshold was derived from 3,000 Monte Carlo simulations
(Forman et al., 1995) and was equivalent to a whole brain
family-wise error threshold of p, .05.
Functional Region of Interest Analysis
Using voxel-wise t tests, SM and EM activations were cal-
culated separately combining all 78 participants. Significant
cluster volumes were used to create functional regions of
interest (fROIs) for each task. The average AUC of all voxels
within each fROI was then calculated for each participant.
For each task, the data from all fROIs were entered into
a principal components analysis (PCA) to further reduce
the number of predictors for the logistic regression analysis
(see Woodard et al., 2010, for details).
Data Analysis
Logistic regression analyses were conducted to examine the
relative accuracy of SM versus EM in predicting cognitive
decline. Our previous research (Woodard et al., 2010)
demonstrated that the combination of APOE e4 status and
SM activation outperformed other predictive models that
included combinations of hippocampal volume, a family
history of AD, and demographic variables. Therefore, we
limited our predictors to only task activation and APOE
e4 status to maintain a reasonable number of subjects-
to-variables and prevent overfitting the model. We tested four
models: APOE e4 status alone (Model 1), APOE e4 and SM
activation (Model 2), APOE e4 and EM activation (Model 3),
and APOE e4 and both SM and EM activation (Model 4).
Nagelkerke R2 values and the concordance (C) indexes
determined the relative fit of each model in predicting
participants’ future cognitive decline. Nagelkerke R2 indi-
cates the importance of the predictors in each model
relative to a perfectly fitting null model (Nagelkerke, 1991).
The C index represents the area under the receiver operating
characteristic curve and indicates the proportion of all
possible pairs of Stable and Declining subjects in which the
Declining subject in the pair had a higher predicted prob-
ability of decline than the Stable subject (Harrell, 2001;
Woodard et al., 2010). Therefore, greater C index values
indicate greater prediction accuracy for a model. For each
logistic regression, values of Nagelkerke R2 and C were
validated with a bootstrapping analysis using 5000 resamples
(Harrell, 2001). Through bootstrapping, holding data out for
cross-validation was not required, and each phase of model
development was revalidated using repeated resampling from
the entire sample (Harrell, 2001; Woodard et al., 2010). The
four logistic regression models were compared on the basis of
their Bayesian Information Criterion (BIC) values, which
account for the number of parameters in each model. Lower
BIC values suggest a better model for optimally predicting
cognitive decline. BIC values can be compared statistically to
determine whether one model fits the data significantly better
than the other model.
RESULTS
On baseline measures, there were no significant differences
between the Stable and Declining groups on the DRS-2
Tot, RALT-Tot, RAVLT-DR, or ADL after controlling for
multiple comparisons (Bonferroni adjust alpha level5 .0125;
0.04/4 tests; see Table 1). At an 18-month follow-up, 27 of 78
participants (34.6%) demonstrated a reduction in neuro-
psychological performance of at least 1 SD on one or more
of the specified neuropsychological measures, indicating
cognitive decline. Of these 27, 22 declined on one measure
only (65DRS-2 Tot, 85RAVLT-Tot, 85RAVLT-DR).
Four participants declined on two measures (35RAVLT-Tot
& RAVLT-DR, 15DRS-2 Tot & RAVLT-Tot), and one
participant declined on all three measures. A 2 (Group)3 2
(Testing Session) ANOVA (analysis of variance) revealed
a significant interaction for all three neuropsychological
measures (RAVLT-Tot, F(1,76)5 14.95; p, .001, partial
h25 .164; RAVLT-DR, F(1,76)5 34.9; p, .001, h25 .315;
DRS-2 tot, F(1,76)5 11.99; p, .001; h25 .136). Two (7.6%)
participants met Petersen criteria for a diagnosis of MCI
(Petersen, 2000). No participants reported impairment in ADLs
at baseline or follow-up. The presence of one or both APOE
e4 alleles was significantly greater in the declining group
(p5 0.02). There were no significant group differences in age,
education, sex, test–retest interval, or fMRI task performance
between the two groups (see Table 1).
Baseline fMRI
The Declining group demonstrated less overall activation on
both the SM and EM tasks as compared to the Stable group
(see Figure 1). As described previously in Woodard et al.
(2010), a voxelwise analysis of the SM task resulted in eight
fROIs (see Table 2). The EM voxelwise analysis resulted in
19 fROIs (see Table 3).
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A PCA conducted on the eight SM fROIs resulted in two
components: ‘‘cortical’’ and ‘‘hippocampal’’ (see Table 2;
Figure 1). The cortical component included significant load-
ings of fROIs in the bilateral posterior cingulate, left and right
angular gyrus, left superior frontal gyrus, and the right
superior middle frontal gyrus. The hippocampal component
included significant loadings for both the left and right
parahippocampal/hippocampal fROIs.
Three components resulted from the PCA of the 19 EM fROIs:
‘‘subcortical,’’ ‘‘frontal,’’ and ‘‘parietal/temporal’’ (see Table 3;
Figure 2). The subcortical component consisted of the left and
right caudate and left and right thalamic fROIs. The frontal
component included the left superior medial gyrus, the left and
right middle frontal gyrus, and left inferior frontal gyrus fROIs.
The parietal/temporal component included left and right middle
temporal gyrus, left angular gyrus, left and right hippocampus,
left lingual gyrus, left cingulate, and left precuneus fROIs.
Cerebellar activation was observed during both the SM
and EM tasks. However, this activation did not demonstrate
significant loadings in either the SM or EM PCA and was
thus excluded from logistic regression analyses.
Logistic Regression Analysis
APOE e4 allele status was found to be a significant predictor
of cognitive decline in our previous study using the SM task
(Woodard et al., 2010) and was, therefore, included in the
logistic regression analyses comparing SM and EM task
activation models in the current study.
Four logistic regression models were evaluated (see
Table 4). Model 1 (APOE e4 alone) was the poorest
fitting model (Nagelkerke R25 .106; C5 .642). Model 2
(SM task1APOE) fit the data much better (Nagelkerke
R25 .285; C5 .787), with significant contributions from
Table 1. Sample characteristics and fMRI behavioral data for stable and declining groups
Stable (n5 51) Declining (n5 27) Between-groups
Mean (SD) Mean (SD) p h2
Sample characteristics
Age (yr) 72.7 (5.1) 73.7 (4.7) .41 0.01
Education (yr) 15.1 (2.5) 14.6 (3.2) .40 0.01
Sex 38F/13M 19F/8M .79 —
Possession of APOE e4 allele 12 (23.5%) 14 (51.9%) .02 —
Retest interval in days 551.7 (43.5) 560.6 (47.0) .41 0.01
SM task performance
% Correct hits (famous names) 93.1 (6.8) 90.4 (7.4) .10 0.04
% Correct rejections (unfamiliar names) 96.9 (4.6) 95.2 (8.8) .27 0.02
d0 3.4 (0.63) 3.1 (0.64) .10 0.04
EM task performance
% Correct hits (old names) 64.0 (13.2) 61.3 (12.3) .38 0.01
% Correct rejections (new names) 88.0 (10.1) 82.7 (15.9) .08 0.04
d0 1.7 (0.56) 1.4 (0.74) .12 0.03
Neuropsychological measures
DRS-2 Total
Baseline 140.7 (3.2) 139.7 (3.8) .28 0.02
Follow-up 139.5 (2.1) 135.6 (5.0)* ,.01 0.21
RAVLT Trials 1-5
Baseline 50.6 (8.8) 46.8 (8.1) .06 0.05
Follow-up 49.5 (7.5) 40.1 (7.1)* ,.01 0.29
RAVLT Delayed Recall
Baseline 10.1 (2.6) 9.0 (2.8) .09 0.04
Follow-up 10.2 (2.4) 6.0 (2.3)* ,.01 0.44
Lawton ADL
Baseline 5.0 (0.0) 5.0 (0.0) — —
Follow-up 4.9 (0.1) 4.9 (0.2) .68 ,0.01
GDS Total
Baseline 2.7 (2.5) 1.4 (1.8) .01 0.07
Follow-up 2.6 (2.6) 1.3 (1.8) .01 0.09
MMSE
Baseline 29.4 (0.8) 28.9 (1.2) .04 0.06
Follow-up 29.5 (1.1) 29.0 (1.2) .07 0.05
Note. APOE5Apolipoprotein E; F5 female; M5male; SM5 semantic memory; EM5 episodic memory; DRS-25Mattis Dementia Rating Scale-2;
RAVLT5Rey Auditory Verbal Learning Test; ADL5Activities of Daily Living; GDS5Geriatric Depression Scale; MMSE5Mini-Mental State Exam.
*Significant decrease (p, .05) from baseline to follow-up.
Hantke-semantic memory fMRI predicts cognitive decline 15
APOE (p5 .003) and both cortical (p5 .01) and hippo-
campal (p5 .03) fMRI components. Model 3 (EM task1
APOE) was not a significantly better fit than Model 2
(Nagelkerke R25 .212; C5 .711) with none of the EM fMRI
components significantly predicting decline. The significance
of APOE e4 as a predictor was reduced to a marginally sig-
nificant level (p5 .051) in Model 3, likely due to a significant
relationship between frontal activation during the episodic
task and APOE e4 inheritance; the frontal component became
significant when e4 was removed from the model (p5 .039).
Model 4 (APOE, SM, and EM) demonstrated the greatest
predictive accuracy of all four models (R25 .422; C5 .837).
However, an examination of BIC values indicated that
Model 4 most likely overfit the data due to the large number
of variables relative to number of participants (see below). Of
interest, APOE e4 and both SM fMRI components were
significant predictors in this model, but the only significant
EM predictor was the parietal-temporal component.
When comparing the models, BIC values favored the SM
model over the combined SM1EM model (p, .036) and the
APOE e4 only model (p, .001) (Table 4). The APOE
e4 model demonstrated a significantly lower BIC than the
EM model (p, .034). Thus, the SM1APOE model fit the
data significantly better and more parsimoniously than either
the EM1APOE model or the APOE only model.
DISCUSSION
In our previous study, we demonstrated that two factors,
baseline semantic memory fMRI activation and APOE
e4 allele status, predicted future cognitive decline in healthy
participants after an 18-month retest interval (Woodard et al.,
2010). The current study extends these findings by focusing
on the type of fMRI activation task used to predict cognitive
decline. The current results indicate that, in combination with
APOE e4 status, fMRI brain activation patterns derived from
an SM activation task were superior to an EM activation task
for predicting cognitive decline after an 18-month interval.
These results suggest the type of activation task used in fMRI
studies may play an important role in accurately identifying
healthy elders at risk for developing future cognitive decline.
Previous research reported that EM fMRI activation
may also be effective in predicting future cognitive decline
(Bookheimer et al., 2000; O’Brien et al., 2010). In contrast,
we found that when SM and EM predictors were combined in
the same model, the EM components did not increase the
overall predictive ability of the model relative to APOE status
alone. Only the parietal-temporal EM component significantly
contributed to prediction of cognitive decline. Whereas there
was extensive overlap in fMRI activation between the SM and
EM tasks (Figure 2), the greater sensitivity of the SM task may
be due to its activation of a more spatially localized network
than the multiple activation networks associated with the
EM task (Figure 2; Tables 2 and 3). Specifically, the SM task
(famous name discrimination) has been previously shown to
activate AD-vulnerable regions such as the hippocampus
and parahippocampal gyrus (Douville et al., 2005) and the
posterior cingulate (Woodard et al., 2007). These regions
overlap with the resting state default mode network (DMN),
which includes the posterior cingulate, medial prefrontal
cortex, medial temporal, and angular gyrus (Raichle et al.,
2001). Recent studies have indicated that the DMN is disrupted
in patients with a diagnosis of MCI or AD (Pihlajamaki &
Sperling, 2009; Rombouts & Scheltens, 2005). In a recent
review, Binder and colleagues (2009) point out that the
DMN overlaps with regions involved in task-activated fMRI
experiments involving semantic processing. Because it
appears to selectively activate brain regions associated with
the DMN, task-activated fMRI that engages the semantic
processing may be more sensitive to future cognitive decline
than episodic memory tasks.
The more diffuse pattern of activation observed with the
EM task may be associated with task difficulty. Importantly,
EM task accuracy was worse than SM task accuracy, which is
Fig. 1. Comparison of semantic and episodic task activation
between the declining and stable groups. The declining group
demonstrated less activation on both the semantic (famous .
unfamiliar names) and episodic (previously seen . novel names)
memory tasks compared to the non-declining group.
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not surprising because episodic memory declines with age
(Cansino, 2009), while semantic memory abilities remain
relatively intact (Nilsson, 2003). The EM task activated
more regions than the semantic task, especially those asso-
ciated with effort and error detection (e.g., frontostriatal,
anterior cingulate). Thus, SM activation may be superior to
EM activation for predicting cognitive decline due to its
ability to effectively stress AD-vulnerable regions, while
minimizing activation of networks associated with task
performance and effort.














1 Bilateral posterior cingulate
cortex, precuneus
115.92 1.44 21 252 25 0.884 0.257
2 Left angular gyrus 245 256 24 0.889 0.266
3 Left superior frontal gyrus 28 30 41 0.805 0.018
4 Right angular gyrus 46 260 27 0.815 0.275
5 Right superior, middle frontal
gyrus
23 17 47 0.839 0.009
6 Left parahippocampal gyrus,
hippocampus
3.15 — 222 221 211 0.269 0.898
7 Right parahippocampal gyrus,
hippocampus
24 223 212 0.053 0.946
8 Right cerebellum 1.03 — 11 275 222 0.425 0.268
PCA5 principal components analysis; fROIs5 functional regions of interest.


















1 Left caudate 16.52 7.18 211 7 12 0.850 0.234 0.273
2 Right caudate 13 6 13 0.850 0.260 0.279
3 Left thalamus 27 217 9 0.839 0.281 0.304
4 Right thalamus 10 216 10 0.827 0.322 0.289
5 Right middle
temporal gyrus
153.24 11.72 46 252 16 0.253 0.742 0.408
6 Left angular gyrus 241 260 34 0.212 0.718 0.446
7 Right hippocampus 28 229 21 0.435 0.718 0.024
8 Left precuneus 0 262 30 0.458 0.684 0.420
9 Left linual gyrus 24 274 211 0.358 0.671 0.290
10 Left hippocampus 221 231 2 0.548 0.584 0.044
11 Left cingulate 0 237 36 0.485 0.584 0.375
12 Left middle
temporal gyrus
259 233 27 0.430 0.526 0.388
13 Left superior medial
gyrus
68.60 2.72 21 50 18 0.271 0.279 0.762
14 Right middle frontal
gyrus
34 11 47 0.233 0.185 0.752
15 Left inferior frontal
gyrus
232 36 8 0.028 0.339 0.692
16 Left superior medial
gyrus
22 34 38 0.342 0.049 0.672
17 Left middle frontal
gyrus
231 13 44 0.380 0.316 0.662
18 Right middle frontal
gyrus
31 46 22 0.392 0.376 0.649
19 Left cerebellum 4.82 — 239 245 250 0.150 20.073 20.114
PCA5 principal components analysis; fROIs5 functional regions of interest.
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Our study found that a greater magnitude of fMRI activa-
tion at baseline was associated with preserved cognitive
performance regardless of task (Figure 1). The study of
Bookheimer et al. (2000) found the opposite results, namely
that increased baseline activation was associated with future
cognitive decline. Our findings, however, are consistent with
those of a more recent study conducted by Lind et al. (2006)
demonstrating that decreased activity predicted future cog-
nitive decline. The precise reasons for the divergent results
are unclear. It should be noted, however, that greater
task-induced activation is consistently observed in asympto-
matic APOE e4-positive individuals relative to non-carriers
(Bondi et al., 2005; Kukolja, Thiel, Eggermann, Zerres, &
Fink, 2010; Seidenberg et al., 2009; Trivedi et al., 2008).
In addition, increased activation in fMRI studies is
frequently observed in older compared to younger subjects
(Cabeza, 2002; Nielson et al., 2006; Nielson, Langenecker, &
Garavan, 2002).
Fig. 2. Semantic and episodic activation functional region of interest (fROI) analysis. A: The top row displays the overlap
of semantic and episodic activation (yellow), regions that activated only during the semantic task (red), and regions that
activated only during the episodic task (blue). A principal components analysis (PCA) of task-related activation for each
condition resulted in the following factor loadings: B: The episodic model consisted of subcortical (yellow), frontal (red),
and parietal/temporal (blue) components; C: The semantic activation model consisted of cortical (blue) and hippocampal
(red) components.
Table 4. Results of the logistic regressions for the relative accuracy of semantic and episodic memory activation in predicting cognitive
decline
Nagelkerke R2 C Index Variables Coeff SE p value BIC
Model 1 0.089 0.637 APOE e4 1.253 0.507 .014 103.09
Model 2 0.285 0.787 APOE e4 1.846 0.612 .003 96.28
SM cortical 20.874 0.309 .013
SM hippocampal 20.699 0.323 .031
Model 3 0.109 0.656 APOE e4 1.057 0.451 .051 109.38
EM subcortical 0.451 0.284 .112
EM Parietal/temporal 20.410 0.270 .129
EM frontal 20.420 0.277 .130
Model 4 0.298 0.786 APOE e4 1.836 0.675 .007 102.68
SM cortical 20.953 0.381 .012
SM hippocampal 20.801 0.337 .018
EM Parietal/temporal 20.645 0.336 .055
EM subcortical 0.466 0.310 .133
EM frontal 20.228 0.340 .502
Note. BIC5Bayesian Information Criterion; APOE5Apolipoprotein E; SM5 semantic memory; EM5 episodic memory.
Nagelkerke R2 and C Index values have been corrected for optimism using bootstrapping (see text for additional description).
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Whether increased activation is helpful or harmful for the
individual is an important question. Park and Reuter-Lorenz
(2009) proposed the Scaffolding Theory of Aging and
Cognition (STAC) to suggest that increased activation in
cognitively intact elders represents a compensatory response
to neural changes associated with normal aging and/or the
impact of emerging disease processes. The increased activity
serves to preserve intact levels of cognitive performance.
Conversely, once cognitive symptoms emerge, brain activity
diminishes since the ‘‘scaffold’’ is no longer successful
in preserving normal performance levels (Han, Bangen, &
Bondi, 2009). In the context of this study, cognitively intact
elders with the e4 gene would be expected to experience
more brain activity than cognitively intact non-carriers
presumably because at least some at-risk individuals
have begun to experience the early stages of AD-related
pathology. In support of this hypothesis, longitudinal fMRI
studies suggest a progression of hyperactivation to hypo-
activation over the course of AD (cf. Machulda et al., 2003;
O’Brien et al., 2010).
The broader literature has demonstrated that comprehen-
sive neuropsychological testing is predictive of impending
cognitive decline (cf. Twamley, Ropacki, & Bondi, 2006).
Thus, some might question the value of using fMRI for
prognostic purposes. The goal of the current study was to use
functional MRI as a surrogate for such testing because
recent studies suggest it might reveal specific patterns that
could eventually serve as better or earlier predictors of cog-
nitive decline. In the current study, the neuropsychological
measures used, specifically the DRS-2 and the RAVLT,
served as criterion variables for assessing cognitive decline,
thereby serving to determine group membership. Thus, they
could not be used also as predictors of cognitive performance
in our models and no other measures were available. How-
ever, the role of cognitive performance in predicting decline
could be examined in this study by using the semantic and
episodic tasks given in the scanner. When including the d0
score for semantic and episodic performance in the model
with the other significant predictors (i.e., adding these beha-
vioral factors to Model 2), the bootstrapped C index was
.80 compared with .79 without them, and neither of the
cognitive performance factors offered significant prediction
(semantic d0 p5 .16; episodic d0 p5 .77). While behavioral
performance may provide adequate prediction of impending
decline, in this context where it was examined directly in
conjunction with fMRI activation, fMRI was superior. One
limitation of this interpretation is that the semantic task
(FNDT) was specifically designed to produce .90% accu-
racy in performance. The value of the design was to limit
task difficulty contributions to activation, but a consequence
of it is a limited ability to discern behavioral differences
between groups.
There are several other limitations of the current study
worth noting. Participant performance on the EM task was
poorer than performance on the SM task. Although only
correct trials were used in the brain imaging analysis, an
easier EM task may have resulted in improved sensitivity for
predicting cognitive decline. Similarly, EM task performance
was dependent upon encoding during the semantic task.
During the EM task, participants in both groups sometimes
judged novel famous names as previously seen due to
familiarity effects with these stimuli, adding to task difficulty.
Furthermore, both the SM and EM tasks used in this study
relied on retrieval in a forced-choice recognition format.
Activation maps based on encoding evoke different brain
systems and may possess different degrees of accuracy
in predicting cognitive decline (Bondi, Salmon, Glasako,
Thomas, & Thal, 1999; Wolk & Dickerson, 2011). Finally,
results of the current study require replication using larger
sample sizes and a longer follow-up interval to draw more
definitive conclusions on the ability of fMRI task activation
to predict conversion to MCI or AD.
In summary, our findings suggest that fMRI activation
during a semantic memory task is more accurate in predicting
future cognitive decline in asymptomatic older adults than
activation during an episodic memory task. Future studies are
required to determine the relative sensitivity of task-activated
fMRI in comparison to other biomarkers (structural MRI,
resting state functional connectivity MRI, amyloid positron
emission tomography scanning, cerebrospinal fluid and
blood analyses) in identifying individuals at-risk for future
cognitive decline or the development of MCI/AD. Results
of this study suggest that semantic memory activation
in combination with APOE e4 status holds promise for
identifying asymptomatic at-risk individuals for inclusion in
primary prevention randomized clinical trials of interventions
designed to prevent or delay cognitive decline.
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